Skip Navigation

VA Tennessee Valley Healthcare System Stem Cell Transplant Center

1310 24th South (11T)
Nashville, TN 37075
(615) 873-6373

Number of Transplants Performed

For detailed information on this center's transplant program (including program description, attending physicians, types of patients treated, cell sources used), please contact the center directly.

Transplants Reported (From Jan. 2011 to Dec. 2012 as reported by the centers)       Unrelated or Related Donor Auto-
logous

(PBSC or marrow)
Total (by transplant type)
Marrow PBSC Cord
Blood
Unrelated Donor
- Adult
2 19 1 --- 22
Unrelated Donor
- Pediatric
0 0 0 --- 0
Related Donor
- Adult
0 36 0 --- 36
Related Donor
- Pediatric
0 0 0 --- 0
Autologous
- Adult
--- --- --- 91 91
Autologous
- Pediatric
--- --- --- 0 0
Total
(by cell source)
2 55 1 91 149

To find centers that perform cord blood transplants, use the Search Tool on this site.



Transplant Results by Patient's Age, Disease Type and Stage

VA Tennessee Valley Healthcare System Stem Cell Transplant Center - Related

Survival by Patient's Age, Disease Type and Stage after Related Donor Transplantation

This report is based on first allogeneic transplants performed between January 2009 and December 2011 using related donors. It only includes patients with known survival status at 1-year post-transplant. In some cases, patients may have been alive at last reported follow-up that was less than one year. Those patients have not been included in this report. The first number represents the number of patients alive at one year post transplant. The second number is a total number of transplanted patients in that particular group.


Diagnosis 0-9 Yrs 10-19 Yrs 20-29 Yrs 30-39 Yrs 40-49 Yrs 50-59 Yrs 60+ Yrs Overall
Acute lymphoblastic leukemia in first complete remission -- -- -- -- 1/1 -- -- 1/1
Acute myelogenous leukemia in first complete remission -- -- 1/1 1/1 1/2 2/3 0/1 5/8
Acute myelogenous leukemia in second complete remission -- -- -- -- -- -- 1/1 1/1
Acute myelogenous leukemia in third or higher complete remission, relapse, or primary induction failure -- -- -- -- 0/2 0/1 1/1 1/4
Chronic lymphocytic leukemia and other chronic leukemia -- -- -- -- -- 1/2 3/3 4/5
Chronic myelogenous leukemia in first chronic phase -- -- 1/1 -- -- -- -- 1/1
Hodgkin lymphoma -- -- -- -- -- -- 0/1 0/1
Multiple myeloma / Plasma cell disorder -- -- -- -- 1/1 -- 1/1 2/2
Myelodysplastic disorders - Refractory anemia, Refractory anemia with ringed sideroblast, Refractory cytopenia with multilineage dysplasia, Refractory cytopenia with multilineage dysplasia and ringed sideroblast -- -- -- -- -- -- 0/1 0/1
Myelodysplastic disorders - Refractory Anemia with excess blasts (with 5-9% brasts (RAEB-1) and 10-19% blasts (RAEB-2)) -- -- -- -- -- 1/1 1/1 2/2
Myelodysplastic disorders - Other MDS -- -- -- -- 0/1 -- 1/2 1/3
Myeloproliferative syndromes -- -- -- -- -- -- 1/2 1/2
Non-Hodgkin lymphoma -- -- -- -- 1/2 0/2 1/2 2/6
Total -- -- 2/2 1/1 4/9 4/9 10/16 21/37

VA Tennessee Valley Healthcare System Stem Cell Transplant Center - Unrelated

Survival by Patient's Age, Disease Type and Stage after Unrelated Donor Transplantation

This report is based on first allogeneic transplants performed between January 2009 and December 2011 using unrelated donors. It only includes patients with known survival status at 1-year post-transplant. In some cases, patients may have been alive at last reported follow-up that was less than one year. Those patients have not been included in this report. The first number represents the number of patients alive at one year post transplant. The second number is a total number of transplanted patients in that particular group.


Diagnosis 0-9 Yrs 10-19 Yrs 20-29 Yrs 30-39 Yrs 40-49 Yrs 50-59 Yrs 60+ Yrs Overall
Acute lymphoblastic leukemia in first complete remission -- -- 1/1 -- 1/1 -- -- 2/2
Acute lymphoblastic leukemia in second complete remission -- -- 0/1 -- -- -- -- 0/1
Acute lymphoblastic leukemia in third or higher complete remission, relapse, or primary induction failure -- -- -- -- 1/1 -- -- 1/1
Acute myelogenous leukemia in first complete remission -- -- -- -- 0/1 0/2 -- 0/3
Acute myelogenous leukemia in second complete remission -- -- -- -- 1/1 1/1 0/2 2/4
Acute myelogenous leukemia in third or higher complete remission, relapse, or primary induction failure -- -- -- -- -- 0/1 1/2 1/3
Chronic lymphocytic leukemia and other chronic leukemia -- -- -- -- 0/1 1/1 3/3 4/5
Chronic myelogenous leukemia in first chronic phase -- -- -- 0/1 0/1 -- -- 0/2
Chronic myelogenous leukemia in accelerated phase or second chronic phase -- -- -- -- 1/1 -- -- 1/1
Myelodysplastic disorders - Refractory anemia, Refractory anemia with ringed sideroblast, Refractory cytopenia with multilineage dysplasia, Refractory cytopenia with multilineage dysplasia and ringed sideroblast -- -- -- -- -- 1/1 -- 1/1
Myelodysplastic disorders - Refractory Anemia with excess blasts (with 5-9% brasts (RAEB-1) and 10-19% blasts (RAEB-2)) -- -- -- -- 0/1 -- -- 0/1
Myelodysplastic disorders - Other MDS -- -- -- -- -- -- 1/1 1/1
Myeloproliferative syndromes -- -- -- -- -- -- 0/1 0/1
Non-Hodgkin lymphoma -- -- -- -- 0/1 -- 3/4 3/5
Other acute leukemia -- -- 1/1 -- -- -- -- 1/1
Severe aplastic anemia -- -- 0/1 -- -- -- -- 0/1
Total -- -- 2/4 0/1 4/9 3/6 8/13 17/33

For detailed information on this center's transplant program (including program description, attending physicians, types of patients treated, cell sources used), please contact the center directly.

Estimated Search & Transplant Costs

The costs for a transplant vary greatly from center to center and depend on factors such as health insurance, disease type and disease stage of the patient, as well as center-specific billing policies. Examples of costs in the search and transplant include:

  • The amount and geographic location of donors tested
  • Testing needed to confirm a match
  • Processing and collecting of tissue-typing samples
  • Donor workup testing needed
  • Getting the marrow, PBSC or cord blood unit for transplant

For the best understanding of costs of transplant and follow-up for a specific transplant center, contact the center's Financial Representative.

help Explain Transplant Costs at Different Centers

Resources for financial information

If you have questions about costs and financial services at this transplant center, you can contact the center's financial representative

Financial services at this center could include:

  • Health insurance information
  • Financial assistance
  • Patient-related resources

Additional Information

Further information about this center, including the number and type of transplants performed in each of the last three years, and the support groups offered, may be found in the BMT InfoNet Transplant Center Directory:
http://www.bmtinfonet.org/transplantcenters.

BMT InfoNet (Blood & Marrow Transplant Information Network) is a nonprofit organization that provides information and emotional support to transplant patients and their families.